Chloramphenicol Eye Drops/Ointment
Brand names: Minims Chloramphenicol, Golden Eye (OTC)
Chloramphenicol eye drops and ointment are a broad-spectrum topical antibacterial used for superficial bacterial eye infections such as acute bacterial conjunctivitis.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Chloramphenicol inhibits bacterial protein synthesis by binding the 50S ribosomal subunit and blocking peptidyl transferase, an action that is bacteriostatic against most susceptible organisms.
Prescribing in practice
- Avoid in patients with a personal or family history of blood dyscrasias or bone-marrow disorders, given the theoretical concern over serious haematological toxicity.
- Reserve for confirmed or strongly suspected bacterial conjunctivitis, as many cases are viral or self-limiting.
- The ointment causes temporary blurring and is useful at night, while drops are used during the day.
Monitoring
Monitor the clinical response and seek review if the infection fails to improve or worsens within a few days of starting treatment.
Counselling the patient
- Complete the recommended course and continue for a short period after symptoms settle.
- Do not share the medicine or eye make-up, and avoid wearing contact lenses during the infection.
- The ointment will blur vision temporarily; apply it at night where possible.
Evidence & guidelines
Topical chloramphenicol is a long-established first-line treatment for acute bacterial conjunctivitis and is available over the counter for this indication in the UK.
Reference: NICE guidance Conjunctivitis; RCGP guidance; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme